Tumor markers are a group of molecules used to diagnose certain diseases, including cancer. These molecules can alter cellular pathways, including those associated with some anemias, by expressing or influencing certain cellular mediators. The present study is based on data obtained from the PubMed database (1970-2019) using the key words 'tumor markers', 'anemia' and 'iron'. We found that some tumor markers can affect hepcidin expression and iron uptake by altering cell pathways. Several other tumor markers also increase in some anemias, so that they can sometimes be used to diagnose and confirm the type of anemia. The role of some tumor markers remains unclear despite the increase in some anemias. In general, some tumor markers are involved in the pathophysiology of a number of anemias or help diagnose anemia. However, studies of the role of tumor markers in the diagnosis, development or progression of anemias have been very limited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.